Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
2.770
-0.015 (-0.54%)
Jul 13, 2026, 11:45 AM EDT - Market open
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $1.01 billion as of July 13, 2026. Its market cap has decreased by -33.69% in one year.
Market Cap
1.01B
Enterprise Value
939.58M
1-Year Change
-33.69%
Ranking
Category
Stock Price
$2.77
Market Cap Chart
Since the IPO on November 4, 2021, Evotec SE's market cap has decreased from $9.19B to $1.01B, a decrease of -89.06%. That is a compound annual growth rate of -37.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 1.01B | -11.59% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | -8.26% |
| Nov 4, 2021 | 9.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phibro Animal Health | 1.30B |
| Alvotech | 1.17B |
| Collegium Pharmaceutical | 1.14B |
| BioAge Labs | 1.08B |
| Cronos Group | 1.03B |
| Glass House Brands | 1.00B |
| Eton Pharmaceuticals | 1.00B |
| Pacira BioSciences | 1.00B |